# Silence Therapeutics plc (SLN): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/sln for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Silence Therapeutics plc is a London, UK-based biotechnology company specializing in the research and development of groundbreaking ribonucleic acid (RNA) therapeutics. Its therapeutic focus areas include hematological, cardiovascular, and various rare and metabolic conditions. Central to their innovative approach is the mRNAi GalNAc Oligonucleotide Discovery platform, which is designed for precise targeting of specific disease-causing genes within the liver. The company's methodology harnesses the body's natural RNA interference (RNAi) mechanism by designing short interfering RNA (siRNA) m...

## Quote & Key Metrics

As of 2026-10-27:

| Metric | Value |
|---|---|
| Price | $19.76 USD |
| Market Cap | $933.3M |
| P/E (TTM) | — |
| EPS (TTM) | −$1.28 |
| 52-Week Range | $4.19 – $19.87 |
| Dividend Yield (TTM) | — |

## Dividend

SLN has no dividend payment history in our records.

## Frequently Asked Questions

### What does Silence Therapeutics plc do?

Silence Therapeutics plc (SLN) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is SLN's market cap?

Silence Therapeutics plc (SLN) has a market capitalization of approximately $933.3 million, as of October 27, 2026, based on the most recent share price and shares outstanding.

### Does SLN pay a dividend?

No, Silence Therapeutics plc (SLN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is SLN profitable?

Silence Therapeutics plc (SLN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has SLN ever paid a dividend?

No. Dividend Data's records show no dividend payments from Silence Therapeutics plc (SLN). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/sln
- Dividend history & safety: https://www.dividenddata.com/stocks/sln/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/sln/earnings
- Financial statements: https://www.dividenddata.com/stocks/sln/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/sln/valuation
- Peer comparison: https://www.dividenddata.com/stocks/sln/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.